Acuity Brands, Inc. (AYI) Stock Forecast
Data as of May 2, 2026Industrials · Current price $289.45 (-0.08%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jan 12, 2026 | Christopher Snyder | Morgan Stanley | $410.00 | +41.6% |
| Jan 9, 2026 | Timothy Wojs | Robert W. Baird | $375.00 | +29.6% |
| Oct 2, 2025 | Christopher Snyder | Morgan Stanley | $425.00 | +46.8% |
| Oct 2, 2025 | Joseph O'Dea | Wells Fargo | $405.00 | +39.9% |
| Sep 2, 2025 | Joseph O'Dea | Wells Fargo | $380.00 | +31.3% |
| Jun 18, 2025 | Timothy Wojs | Robert W. Baird | $315.00 | +8.8% |
| Apr 4, 2025 | Christopher Snyder | Morgan Stanley | $335.00 | +15.7% |
| Apr 4, 2025 | Timothy Wojs | Robert W. Baird | $295.00 | +1.9% |
| Apr 4, 2025 | Joseph O'Dea | Wells Fargo | $275.00 | -5.0% |
| Mar 28, 2025 | Joseph O'Dea | Wells Fargo | $290.00 | +0.2% |
| Jan 9, 2025 | Christopher Glynn | Oppenheimer | $380.00 | +31.3% |
| Jan 9, 2025 | Joseph O'Dea | Wells Fargo | $336.00 | +16.1% |
| Jan 7, 2025 | Joseph O'Dea | Wells Fargo | $320.00 | +10.6% |
| Oct 2, 2024 | Joseph O'Dea | Wells Fargo | $305.00 | +5.4% |
| Oct 1, 2024 | Christopher Glynn | Oppenheimer | $370.00 | +27.8% |
| Sep 24, 2024 | Joseph O'Dea | Wells Fargo | $289.00 | -0.2% |
| Jun 28, 2024 | Joseph O'Dea | Wells Fargo | $260.00 | -10.2% |
| Jun 18, 2024 | Timothy Wojs | Robert W. Baird | $280.00 | -3.3% |
| Apr 4, 2024 | Joseph O\'Dea | Wells Fargo | $295.00 | +1.9% |
| Apr 4, 2024 | Christopher Glynn | Oppenheimer | $315.00 | +8.8% |
Top Analysts Covering AYI
AYI vs Sector & Market
| Metric | AYI | Industrials Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.60 | 2.41 | 2.41 |
| Analyst Count | 5 | 8 | 18 |
| Target Upside | +35.6% | +84.9% | +14.9% |
| P/E Ratio | 21.22 | 28.16 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-08-31 | $4.55B | $4.62B | $4.68B | 7 |
| 2026-11-28 | $1.16B | $1.19B | $1.22B | 3 |
| 2027-02-28 | $1.08B | $1.11B | $1.14B | 3 |
| 2027-05-28 | $1.21B | $1.24B | $1.28B | 3 |
| 2027-08-28 | $1.26B | $1.30B | $1.34B | 3 |
| 2027-08-31 | $4.82B | $4.86B | $4.90B | 7 |
| 2027-11-28 | $1.25B | $1.28B | $1.32B | 3 |
| 2028-02-28 | $1.16B | $1.19B | $1.23B | 2 |
| 2028-05-28 | $1.31B | $1.35B | $1.39B | 2 |
| 2028-08-28 | $1.35B | $1.38B | $1.42B | 2 |
| 2028-08-31 | $5.10B | $5.11B | $5.11B | 6 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-08-31 | $19.13 | $19.57 | $20.35 | 6 |
| 2026-11-28 | $4.87 | $5.04 | $5.23 | 3 |
| 2027-02-28 | $4.41 | $4.57 | $4.74 | 2 |
| 2027-05-28 | $5.46 | $5.65 | $5.86 | 2 |
| 2027-08-28 | $5.85 | $6.06 | $6.28 | 2 |
| 2027-08-31 | $20.72 | $21.33 | $21.77 | 6 |
| 2027-11-28 | $5.25 | $5.43 | $5.63 | 2 |
| 2028-02-28 | $4.94 | $5.11 | $5.30 | 3 |
| 2028-05-28 | $5.97 | $6.18 | $6.41 | 3 |
| 2028-08-28 | $6.32 | $6.54 | $6.78 | 3 |
| 2028-08-31 | $22.74 | $23.10 | $23.45 | 2 |
Frequently Asked Questions
What is the analyst consensus for AYI?
The consensus among 5 analysts covering Acuity Brands, Inc. (AYI) is Hold with an average price target of $392.50.
What is the highest price target for AYI?
The highest price target for AYI is $425.00, set by Christopher Snyder at Morgan Stanley on 2025-10-02.
What is the lowest price target for AYI?
The lowest price target for AYI is $170.00, set by Timothy Wojs at Robert W. Baird on 2023-10-04.
How many analysts cover AYI?
5 analysts have issued ratings for Acuity Brands, Inc. in the past 12 months.
Is AYI a buy or sell right now?
Based on 5 analyst ratings, AYI has a consensus rating of Hold (2.60/5) with a +35.6% upside to the consensus target of $392.50.
What are the earnings estimates for AYI?
Analysts estimate AYI will report EPS of $19.57 for the period ending 2026-08-31, with revenue estimated at $4.62B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.